Strides Arcolab receives 2nd injectable ANDA approval for Tobramyc
New Delhi, Mar 12 (UNI) Strides Arcolab Ltd today announced its second Abbreviated New Drug Application (ANDA) approval for Tobramycin 40 mg/mL.
The product is licensed to Akorn-Strides, LLC, which is a Joint Venture that was formed in 2004 by Akorn, Inc and Strides Arcolab Ltd.
Tobromycin is the second approval amongst 22 sterile submissions the company has submitted with US FDA.
UNI BJR PBB RN1458
More From
-
Gold Silver Rate Today, 9 March 2026: City-Wise Prices, MCX Gold and Silver Ease Slightly After Rally -
Chinese Spy Ship Liaowang-1 Spotted Near Oman: Why Its Presence Near Oman Is Concerning For US Military -
Pune Gold Rate Today: Check Gold Prices For 18K, 22K, 24K in Pune -
Bangalore Gold Silver Rate Today, March 9, 2026: Gold and Silver Prices Fall as US Dollar Strengthens -
Who Is Nishant Kumar: Education, Personal Life and Possible Political Role -
Ind Vs NZ T20 World Cup Phalodi Satta Bazar Prediction: Know Who Will Win In India vs New Zealand Final -
Vijay-NDA Alliance On Cards? Pawan Kalyan Reportedly Reaches Out to TVK Chief -
Who Was Mojtaba Khamenei’s Wife Zahra Haddad-Adel and What Do We Know About Her? -
Trisha Hits Back at Parthiban: 'Crude Words Say More About the Speaker' -
India vs New Zealand T20 World Cup 2026 Final: Five Positive Signs Favouring India Before Title Clash -
IND vs NZ Final Live: When and Where to Watch India vs New Zealand T20 World Cup 2026 Title Clash -
Ind vs NZ T20 World Cup 2026: New Zealand Needs 256 Runs To Beat India And Win The World Cup
Click it and Unblock the Notifications
Sign in with Google